Multiple Myeloma: How Far Have We Come?

Anderson, Kenneth C.
January 2003
Mayo Clinic Proceedings;Jan2003, Vol. 78 Issue 1, p15
Academic Journal
Editorial. Discusses Robert A. Kyle and colleagues' article on symptoms and signs, prognostic factors, complications and treatment outcomes of patients with diagnosed multiple myeloma (MM) evaluated at the Mayo Clinic from 1985 to 1998. Historical review of how the diagnosis and treatment of MM have evolved; Benchmark to establish the current state of the art in MM; Platform for future biologically based strategies to improve diagnosis, treatment and patient outcome.


Related Articles

  • The Monoclonal Gammopathies (Book). Barnett, Eugene V. // Annals of Internal Medicine;Aug77, Vol. 87 Issue 2, p256 

    Reviews the book "The Monoclonal Gammopathies: Multiple Myeloma and Related Plasma-Cell Disorders," by Robert A. Kyle and Edwin D. Bayrd.

  • Multiple myeloma and related conditions. Singer, Charles R J // BMJ: British Medical Journal (International Edition);03/29/97, Vol. 314 Issue 7085, p960 

    Features the treatment of multiple myeloma. Clinical features; Investigations and diagnosis; Conditions associated with M proteins; Minimal diagnostic criteria; Management and clinical course.

  • LETTER FROM THE EDITOR-IN-CHIEF. Lonial, Sagar // Personalized Medicine in Oncology;Feb2014, Vol. 3 Issue 1, p24 

    No abstract available.

  • The Myeloma Survival Guide. Faiman, Beth // Oncology Nurse-APN/PA;Sep/Oct2014, Vol. 7 Issue 5, p19 

    No abstract available.

  • Expert comment. Lobban, Lois // Nursing Standard;5/28/2014, Vol. 28 Issue 39, p18 

    In this article the author offers her opinions on the treatment of patients with multiple myeloma.

  • Multiple myeloma incidence. Harras, Angela // JNCI: Journal of the National Cancer Institute;1/05/94, Vol. 86 Issue 1, p9 

    Presents a graph showing the incidence of multiple myeloma in Americans in 1993. Prognosis; Genetic and environmental links.

  • International uniform response criteria for multiple myeloma. Durie, B G M; Harousseau, J-L; Miguel, J S; Bladé, J; Barlogie, B; Anderson, K; Gertz, M; Dimopoulos, M; Westin, J; Sonneveld, P; Ludwig, H; Gahrton, G; Beksac, M; Crowley, J; Belch, A; Boccadaro, M; Turesson, I; Joshua, D; Vesole, D; Kyle, R // Leukemia (08876924);Dec2006, Vol. 20 Issue 12, p2220 

    A correction to the article "International Uniform Response Criteria for Multiple Myeloma" that was published in a previous issue is presented.

  • Erratum to: pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients. Buda, Gabriele; Orciuolo, Enrico; Galimberti, Sara; Pelosini, Matteo; Petrini, Mario // Annals of Hematology;Jul2011, Vol. 90 Issue 7, p863 

    A correction to the article "Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients," that was published in the previous issue is presented.

  • International uniform response criteria for multiple myeloma. Durie1, B G M; Harousseau2, J-L; Miguel3, J S; Bladé4, J; Barlogie5, B; Anderson6, K; Gertz7, M; Dimopoulos8, M; Westin9, J; Sonneveld10, P; Ludwig11, H; Gahrton12, G; Beksac13, M; Crowley14, J; Belch15, A; Boccadaro16, M; Turesson17, I; Joshua18, D; Vesole19, D; Kyle7, R // Leukemia (08876924);May2007, Vol. 21 Issue 5, p1134 

    A correction to the article about multiple myeloma that was published in the 2006 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics